West Pharmaceutical Services Inc (WST) financials · P/E 35, rev $1.72B
West Pharmaceutical Services Inc (WST) P/E 35, rev $1.72B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $3.07B | $2.89B |
| Cost of Revenue | $1.97B | $1.89B |
| Gross Profit | $1.10B | $998.5M |
| Operating Income | $584.9M | $569.9M |
| Net Income | $493.7M | $492.7M |
| EPS (Diluted) | $6.79 | $6.69 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $4.27B | $3.64B |
| Current Assets | $1.98B | $1.54B |
| Cash & Equivalents | $791.3M | $484.6M |
| Inventory | $443.9M | $377.0M |
| PP&E | $1.73B | $1.58B |
| Total Liabilities | $1.09B | $961.1M |
| Current Liabilities | $654.9M | $550.4M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $202.8M | $202.6M |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $3.18B | $2.68B |
| Retained Earnings | $4.37B | $3.96B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $754.8M | $653.4M |
| CapEx | $285.9M | $377.0M |
| Investing Cash Flow | -$285.9M | -$378.7M |
| Financing Cash Flow | -$185.1M | -$622.6M |
| Dividends Paid | $61.2M | $59.1M |
| Net Change in Cash | $306.7M | -$369.3M |
| Free Cash Flow | $468.9M | $276.4M |
FAQ
What is WST P/E and revenue?
West Pharmaceutical Services Inc (WST) P/E 35, rev $1.72B.
What is WST revenue?
West Pharmaceutical Services Inc last cached revenue is $3.07B (FY2025).
Is WST profitable?
West Pharmaceutical Services Inc last cached net income is $493.7M.
What are WST total assets?
West Pharmaceutical Services Inc last cached total assets are $4.27B.
What is WST free cash flow?
West Pharmaceutical Services Inc last cached free cash flow is $468.9M.
Not investment advice. Cached statements, not a live tape.